Yanling Cao
Managing Director @ Boyu Capital
Cambridge, United States
Yanling Cao is a Series A investor at Boyu Capital in Cambridge focused on Life Science and Biotechnology. Yanling Cao
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Yanling Cao invests in
Stages Yanling Cao invests in
Countries Yanling Cao invests in
Investment Focus
Industry
- Life Science 2 (100%)
- Biotechnology 2 (100%)
- Therapeutics 1 (50%)
- Pharmaceutical 1 (50%)
Country
- China 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
D3 Bio
|
D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path. | $200M / Series A / Nov 17, 2020 | |
LifeMine Therapeutics
|
Discovering powerful new drugs from eukaryotic microbes by combining Genomics with AI and Synthetic Biology. Founded by Gregory Verdine, PhD, Rick Klausner, MD and WeiQing Zhou, MBA, LifeMine Therapeutics is headquartered in Cambridge, Massachusetts. | $70M / Series A / Sep 18, 2017 |
Co-Investors
About Boyu Capital
Boyu Capital Consultancy Co. Ltd is a private equity firm specializing in investments in China. Boyu Capital Consultancy Co. Ltd was founded on September 28, 2010 and is based in Hong Kong with an additional office in Beijing, China.
Boyu Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Mary Ma
Co-Founder and Chairman
|
|||
|
Yanling Cao
Managing Director
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Yanling Cao invest in?
Yanling Cao invests primarily in Life Science, Biotechnology and Therapeutics startups, most often at Series A stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Yanling Cao last invest?
The most recent investment recorded for Yanling Cao closed in Nov 2020. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
